AI-Native Scoping Reviews & Evidence Mapping

PCSK9 base editing is moving from experimental promise toward clinical reality, with single-dose therapies already producing durable LDL-C reductions in both primates and early human studies. The full evidence map reveals which delivery platforms, editing strategies, and safety signals are driving this transition—and where the remaining uncertainties still lie.

Surgery does not end when the operation ends: this review shows that across oncology, bariatrics, orthopedics, transplantation, and vascular care, postoperative medication adherence is often the hidden determinant of recurrence, complications, and survival. The full read is worth it because it separates where adherence reliably fails, which barriers drive that failure, and which interventions actually help keep patients on treatment after discharge.

Giant cell myocarditis is rare, but the evidence map shows why it should never be treated as a diagnostic afterthought: survival depends on early biopsy, rapid combination immunosuppression, and timely escalation to mechanical support or transplantation. The full review distills 169 references into a practical map of prognosis, arrhythmia risk, cardiac sarcoidosis overlap, relapse surveillance, and the unresolved gaps that still shape real-world management.

Falsified medical products are not a niche drug-safety problem, but a supply-chain failure spanning medicines, devices, online pharmacies, informal markets, and weak regulatory systems. The full evidence map shows where risk concentrates — from semaglutide and PDE-5 products to vaccines, antibiotics, devices, and digital marketplaces — and which detection, reporting, and regulatory tools can realistically close the gaps.

Medical podcasts are no longer just convenient audio extras — this evidence map shows where they actually improve knowledge, confidence, clinical skills, CME behavior, and patient-facing communication, and where their impact remains limited. The full read separates strong educational signals from hype, including AI-generated podcasts, quality-transparency gaps, listener behavior, and the practical standards needed before podcasts can be trusted as serious medical-learning infrastructure.

Buttock augmentation safety is not defined by aesthetics alone: this evidence map shows that risk concentrates around where material is placed and what material is used, with subcutaneous image-guided fat grafting looking far safer than intramuscular injection or illicit permanent fillers. The full read separates low-complication fat-grafting and implant techniques from the dangerous edge cases — fat embolism, silicone embolism, septic shock, granulomatous hypercalcemia, sciatic nerve injury, and difficult filler migration — giving clinicians and patients a practical map of where buttock augmentation becomes unsafe.

Research automation is no longer a futuristic add-on — this review shows where it is already transforming science, from trial recruitment and evidence synthesis to laboratory workflows and multimodal data pipelines, often cutting manual work by more than 90% without sacrificing performance. Across 1,679 original studies, the paper maps not only where automation truly delivers speed, scale, and reproducibility, but also where human oversight remains the difference between safe acceleration and costly over-trust.

Mobile health clinics are not just outreach vans; they emerge as equity infrastructure that can bring screening, diagnosis, treatment initiation, and trust directly to populations fixed-site care often misses. The full evidence map shows where MHCs truly deliver value, where continuity breaks down after the first encounter, and which models are most likely to convert access into sustained care.

Digital twins are moving beyond engineering hype into practical decision systems for medicine, industry, infrastructure, and public health—linking real-world data to virtual models that can predict, optimize, and guide action. This full evidence map of 220 references and 1,347 original studies shows where digital twins already deliver measurable signals, where they remain experimental, and which domains are closest to real-world clinical or operational impact.

Transhumanism is no longer only a futuristic philosophy: this evidence map shows how wearables, biohacking, microchipping, XR, and human–machine prototypes are already reshaping identity, embodiment, and social acceptance. The full review separates empirical signals from speculative claims, showing where augmentation appears practical, emotionally driven, culturally normalized, or ethically contested.